NFE2L2 and diabetic kidney disease: Therefore, as an important antioxidative transcription factor, Nrf2 is a potential activator of NLRP3 inflammasome in various pathological conditions, such as depressive-like behaviors, cerebral ischemia-reperfusion injury, and diabetic nephropathy [37–39].